Department of Ultrasound, Fengtai District, Beijing Tiantan Hospital, Capital Medical University, No.119 South Fourth Ring West Road, BeijingBeijing, 100160, China.
Cancer Imaging. 2022 Aug 17;22(1):41. doi: 10.1186/s40644-022-00478-y.
The aim of this study is to propose a new TI-RADS and compare it with the American College of Radiology (2017 ACR)-TI-RADS and the 2020 Chinese (2020 C)-TI-RADS.
A retrospective analysis of 749 thyroid nodules was performed. Based on the calculated odds ratio of ultrasonic signs between benign and malignant nodules, a new thyroid nodule score and malignancy rate were calculated. A receiver operating characteristic curve was drawn to analyze the new system's effectiveness in the differential diagnosis of benign and malignant thyroid nodules and was compared with the 2020 C-TI-RADS and 2017 ACR-TI-RADS. Five ultrasound physicians with different qualifications graded another 123 thyroid nodules according to the 2017ACR-TI-RADS, 2020 C-TI-RADS, and the newly proposed TI-RADS. Intergroup and intragroup consistency was evaluated using the Kappa test and intraclass correlation coefficient (ICC) test.
In summary, we proposed a new TI-RADS, namely, sTI-RADS, which was obtained using a simple assignment method with higher specificity, accuracy, positive predictive value, and Youden index than the 2017 ACR-TI-RADS and 2020 C-TI-RADS.
本研究旨在提出一种新的 TI-RADS,并将其与美国放射学院(2017 ACR)-TI-RADS 和 2020 年中国(2020 C)-TI-RADS进行比较。
对 749 个甲状腺结节进行回顾性分析。基于超声征象在良性和恶性结节之间的计算比值比,计算出新的甲状腺结节评分和恶性率。绘制受试者工作特征曲线,分析新系统在鉴别诊断良性和恶性甲状腺结节中的有效性,并与 2020 C-TI-RADS 和 2017 ACR-TI-RADS 进行比较。5 名不同资质的超声医师根据 2017 ACR-TI-RADS、2020 C-TI-RADS 和新提出的 TI-RADS 对另外 123 个甲状腺结节进行分级。使用 Kappa 检验和组内相关系数(ICC)检验评估组间和组内一致性。
1)新的甲状腺结节评分分为 0、1、2、3、4 和 5 分,恶性率分别为 1.52%、7.69%、38.24%、76.00%、90.75%和 93.75%。使用 3 分作为诊断良恶性甲状腺结节的截断值,灵敏度和特异度分别为 94.03%和 67.39%,均高于 2017 ACR-TI-RADS 和 2020 C-TI-RADS。建立了简化的 TI-RADS,即 sTI-RADS:sTI-RADS 3(0 分),恶性率<2%;sTI-RADS 4a(1 分),恶性率 2-10%;sTI-RADS 4b(2 分),恶性率 10-50%;sTI-RADS 4(3 分),恶性率 50-90%;sTI-RADS 5(4 分和 5 分),恶性率>90%。2)5 名超声医生根据 2017 ACR-TI-RADS、2020 C-TI-RADS 和 sTI-RADS 对甲状腺结节进行分级。所有检测的组内一致性均较好;ICC 分别为 0.86(0.82-0.90)、0.84(0.78-0.88)和 0.88(0.84-0.91),而只有 sTI-RADS 具有良好的组间一致性。
总之,我们提出了一种新的 TI-RADS,即 sTI-RADS,它采用了一种简单的赋值方法,与 2017 ACR-TI-RADS 和 2020 C-TI-RADS 相比,具有更高的特异性、准确性、阳性预测值和约登指数。